When did scientists start studying red light therapy?

Scientific study of red light therapy has undergone a dramatic transformation in both volume and rigor since its inception. While isolated experiments occurred in the late 19th century, systematic scientific inquiry into the specific effects of low-level red and near-infrared light began in earnest in the late 1960s following Endre Mester’s work. The 1970s saw a surge of research, primarily behind the Iron Curtain. Scientists in the Soviet Union, Hungary, and China published hundreds of papers on LLLT, exploring its effects on wound healing, pain relief, and nerve regeneration. However, much of this early research was inaccessible to the Western world due to language barriers and the Cold War, leading to a fragmented understanding of the therapy globally.

In the 1980s, the scientific focus shifted towards understanding the mechanism of action. This decade was crucial because it moved the field from empirical observation ("it works") to biochemical explanation ("how it works"). Dr. Tiina Karu’s groundbreaking research in Russia during this time identified the mitochondrial respiratory chain as the target of red light. Simultaneously, researchers in the US and Europe began conducting more controlled clinical trials, though many were still small-scale and lacked the rigorous double-blind standards seen in pharmaceutical research. The inconsistency in study parameters (wavelength, dose, duration) remained a significant hurdle, often leading to conflicting conclusions in meta-analyses.

The 1990s marked a turning point with the involvement of NASA. The space agency’s intense interest in growing plants in space and maintaining astronaut health led to a new wave of high-quality, well-funded research. NASA’s studies were meticulously documented and published in reputable peer-reviewed journals, bringing a level of credibility to the field that it had previously lacked. This era also saw the first major conferences dedicated to photobiomodulation, where scientists from around the world could share data and standardize terminology.

From the 2000s to the present day, the volume of research has exploded. The advent of the internet made global collaboration easier, and the term "photobiomodulation" was adopted to unify the field. According to databases like PubMed, the number of published studies on PBM has grown exponentially, with thousands of papers now available covering everything from traumatic brain injury and neuropathy to cosmetic dermatology and mental health. Modern studies are increasingly sophisticated, utilizing advanced imaging techniques to track cellular changes and conducting large-scale, multi-center randomized controlled trials (RCTs).

Furthermore, the quality of research has improved significantly. Early studies often suffered from poor dosimetry (measurement of light dose), making replication difficult. Today, journals require detailed reporting of irradiance, fluence, and wavelength, ensuring that studies can be accurately reproduced. The establishment of organizations like the World Association for Photobiomodulation Therapy (WALT) has further standardized guidelines. While skepticism still exists in some corners of the medical community, the sheer weight of high-quality evidence accumulated over the last 50 years has firmly established red light therapy as a legitimate subject of serious scientific inquiry.